Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial

Open Access

Peer-reviewed

Research Article

David R. Clemmons ,

* E-mail: endocrine@med.unc.edu

Affiliation Division of Endocrinology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
⨯
Sam Miller,

Affiliation SAM Clinical Research Center, San Antonio, Texas, United States of America
⨯
Jean-Claude Mamputu

Affiliation Theratechnologies Inc., Montreal, Quebec, Canada

http://orcid.org/0000-0001-8493-959X

⨯

Reader Comments (0)

Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Cholesterol
Is the Subject Area "Cholesterol" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Ingestion
Is the Subject Area "Ingestion" applicable to this article?

Thanks for your feedback.
HbA1c
Is the Subject Area "HbA1c" applicable to this article?

Thanks for your feedback.
Blood sugar
Is the Subject Area "Blood sugar" applicable to this article?

Thanks for your feedback.
Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.